Disparities and barriers to the access of biologics in moderate‐to‐severe adult psoriasis
International Journal of Dermatology · 2024-10 · 63 (10) · 1293-1301
DOI: 10.1111/ijd.17236 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Dermatology, online erschienen am 06.06.2024. Verfasst von Vincent Wan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Psoriasis, Health Services Accessibility, Biological Products, Healthcare Disparities. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Psoriasis is a chronic, relapsing inflammatory skin disorder that is associated with substantial physical and psychosocial comorbidity. Although biologic agents have offered transformative therapeutic advantages to those unresponsive to traditional treatments, data from recent literature indicate significant undertreatment of certain populations, highlighting potential barriers to access. This review aims to comprehensively elucidate barriers to biological therapy, addressing a recognized gap in the current literature. A search was conducted using MEDLINE, Embase, and Web of Science to investigate the obstacles and disparities that prevent access to biologic treatments in biologic‐naïve psoriatic patients. Emergent themes were then systematically categorized into five primary domains: patient‐level, prescriber‐level, medicine‐level, organizational‐, and external environment‐level factors. Our results demonstrate pronounced barriers and disparities encompassing increased age, race, socioeconomic status, rural location, cost and insurance, and insufficient knowledge that may hinder access to biologic treatments among psoriatic patients. Further research on how these barriers can be effectively addressed is needed to optimize treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
- Faculté de Médecine, Université de Montréal, Montréal, QC, Canada.
- Memorial University of Newfoundland Faculty of Medicine, St. Johns, NL, Canada.
- University of British Columbia, Vancouver, BC, Canada.
- Toronto Dermatology Centre, Toronto, ON, Canada.
ORCID-Profile: Vincent Wan, Lorena A Mija, Parsa Abdi, Ilya Mukovozov
Zitieren
APA
Wan, V., Habibi, A., Mija, L. A., Abdi, P., Selvakumar, R., & Mukovozov, I. (2024). Disparities and barriers to the access of biologics in moderate‐to‐severe adult psoriasis. International Journal of Dermatology, 63(10), 1293-1301. https://doi.org/10.1111/ijd.17236
Vancouver
Wan V, Habibi A, Mija LA, Abdi P, Selvakumar R, Mukovozov I. Disparities and barriers to the access of biologics in moderate‐to‐severe adult psoriasis. International Journal of Dermatology. 2024;63(10):1293-1301. doi:10.1111/ijd.17236
BibTeX
@article{Wan2024,
author = {Wan, Vincent and Habibi, Alireza and Mija, Lorena A and Abdi, Parsa and Selvakumar, Rishika and Mukovozov, Ilya},
title = {Disparities and barriers to the access of biologics in moderate‐to‐severe adult psoriasis},
journal = {International Journal of Dermatology},
year = {2024},
volume = {63},
number = {10},
pages = {1293--1301},
doi = {10.1111/ijd.17236}
}
EUVIMED